2 months ago
CORT
AnalystsJoon LeeJoon Lee's Stock Forecasts
AnalystsJoon Lee
Sectors:
Industries:
Analyst Ranking
Top 2%
#92 out of 4906 analysts
Average Return
+32.65%
Win Rate
53%61 out of 115
Risk vs Reward
Poor
Good
Joon Lee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Verona Pharma PLCVRNA | +537.62% | $14.46 | $92.20 | 2024-06-27 - 2025-06-13 | Strong Buy |
Viking Therapeutics IncVKTX | +470.38% | $10.87 | $62.00 | 2023-10-01 - 2024-10-01 | Strong Buy |
Intellia Therapeutics IncNTLA | +418.87% | $25.44 | $132.00 | 2020-10-26 - 2021-10-26 | Strong Buy |
Viking Therapeutics IncVKTX | +414.75% | $15.93 | $82.00 | 2023-03-28 - 2024-03-28 | Strong Buy |
Praxis Precision Medicines IncPRAX | +346.23% | $16.16 | $72.11 | 2023-12-03 - 2024-12-03 | Strong Buy |
Joon Lee Analyst Color
Get additional color on Joon Lee's coverage of popular stocks
4 months ago
AXSM
4 months ago
CRSP
4 months ago
AXSM
5 months ago
ARGX
5 months ago
AXSM
5 months ago
VRNA
7 months ago
WVE
7 months ago
CPRX
7 months ago
ARGX
8 months ago
CRMD
8 months ago
VRNA
9 months ago
CORT
10 months ago
CPRX
a year ago
ARGX
a year ago
VRNA
a year ago
ARGX
a year ago
CORT
a year ago
ARGX
a year ago
VKTX
a year ago
CORT
2 years ago
EDIT
2 years ago
CORT
2 years ago
TSHA
2 years ago
SAGE
Joon Lee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Viking Therapeutics IncVKTX | 8 | Strong Buy | $75.00 | +187.58% | Reiterates | 2 months ago |
Arvinas IncARVN | 6 | Strong Buy | $21.00 | +184.17% | Maintains | 2 months ago |
Corcept Therapeutics IncCORT | 8 | Strong Buy | $150.00 | +114.10% | Maintains | 2 months ago |
Intellia Therapeutics IncNTLA | 4 | Strong Buy | $50.00 | +501.68% | Maintains | 3 months ago |
Praxis Precision Medicines IncPRAX | 5 | Strong Buy | $85.00 | +91.87% | Maintains | 3 months ago |
Axsome Therapeutics IncAXSM | 5 | Strong Buy | $200.00 | +92.12% | Maintains | 4 months ago |
Crispr Therapeutics AgCRSP | 5 | Strong Buy | $120.00 | +190.14% | Maintains | 4 months ago |
Vertex Pharmaceuticals IncVRTX | 3 | Strong Buy | $520.00 | +14.17% | Maintains | 4 months ago |
Larimar Therapeutics IncLRMR | 1 | Strong Buy | $18.00 | +525.00% | Initiates Coverage On | 5 months ago |
Argenx SeARGX | 12 | Strong Buy | $700.00 | +21.13% | Reiterates | 5 months ago |
Verona Pharma PLCVRNA | 6 | Strong Buy | $57.00 | -38.18% | Reiterates | 5 months ago |
Solid Biosciences IncSLDB | 1 | Strong Buy | $16.00 | +254.77% | Initiates Coverage On | 5 months ago |
Wave Life Sciences LtdWVE | 3 | Strong Buy | $36.00 | +417.99% | Maintains | 7 months ago |
Catalyst Pharmaceuticals IncCPRX | 7 | Strong Buy | $36.00 | +53.00% | Maintains | 7 months ago |
Editas Medicine IncEDIT | 7 | Strong Buy | $8.00 | +306.09% | Maintains | 7 months ago |
Sage Therapeutics IncSAGE | 7 | Hold | $8.00 | +19.40% | Maintains | 8 months ago |
Cormedix IncCRMD | 6 | Strong Buy | $17.00 | +16.76% | Maintains | 8 months ago |
Longboard Pharmaceuticals IncLBPH | 2 | Hold | $60.00 | +0.03% | Downgrades | 8 months ago |
Biomarin Pharmaceutical IncBMRN | 2 | Strong Buy | $90.00 | +60.09% | Maintains | 9 months ago |
Adverum Biotechnologies IncADVM | 6 | Strong Buy | $40.00 | +1,526.02% | Maintains | 10 months ago |
Marinus Pharmaceuticals IncMRNS | 7 | Strong Buy | $10.00 | +1,718.18% | Maintains | a year ago |
Jazz Pharmaceuticals PLCJAZZ | 2 | Strong Buy | $200.00 | N/A | Reiterates | a year ago |
Taysha Gene Therapies IncTSHA | 7 | Strong Buy | $5.00 | N/A | Maintains | 2 years ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Concert Pharmaceuticals IncCNCE | 2 | Strong Buy | $25.00 | N/A | Maintains | 3 years ago |
Aptinyx IncAPTX | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cyclerion Therapeutics IncCYCN | 1 | Strong Buy | $280.00 | N/A | Initiates Coverage On | 4 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | $50.00 | N/A | Upgrades | 4 years ago |
Translate Bio IncTBIO1 | 2 | Hold | $360.00 | N/A | Downgrades | 4 years ago |
Anaptysbio IncANAB | 1 | Strong Buy | $34.00 | N/A | Upgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.